Innovision Limited (INNOVISION) — deviation variation | 12 August 2026

· NSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
No deviation in fund utilization reported for Q1 FY2026
💡 Investor Takeaway
Funds were fully deployed as planned with no material deviations, indicating disciplined capital allocation.

Innovision Limited disclosed no deviation in fund utilization for its March 2026 quarter, confirming full deployment of ₹2,097.99 million raised via IPO on 23 March 2026. Funds were allocated to working capital, EPFO/ESCI/GST payments for NHAI projects, and bank guarantees, with no material variances reported.

📄 View Original Announcement (PDF)

About Innovision Limited (INNOVISION)

Services · Miscellaneous · Listed on NSE

Market Cap: ₹650.34 Cr P/E: 27.1 ROE: 20.1% ROCE: 21.8%

View full INNOVISION stock details →

📡 Get AI alerts when INNOVISION files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track INNOVISION — Free

📊 More INNOVISION filings

See all INNOVISION filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when INNOVISION files new disclosures

Track INNOVISION filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track INNOVISION — Free

Free account · 2 AI queries/day